1. Home
  2. DEA vs PCRX Comparison

DEA vs PCRX Comparison

Compare DEA & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Easterly Government Properties Inc.

DEA

Easterly Government Properties Inc.

HOLD

Current Price

$22.99

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.72

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEA
PCRX
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
DEA
PCRX
Price
$22.99
$23.72
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$23.49
$30.25
AVG Volume (30 Days)
335.1K
572.7K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
7.92%
N/A
EPS Growth
50.00
107.44
EPS
0.27
0.16
Revenue
$336,099,000.00
$541,533,000.00
Revenue This Year
$5.20
$6.78
Revenue Next Year
$3.63
$8.54
P/E Ratio
$84.26
$148.81
Revenue Growth
11.27
26.04
52 Week Low
$7.88
$18.80
52 Week High
$24.94
$27.99

Technical Indicators

Market Signals
Indicator
DEA
PCRX
Relative Strength Index (RSI) 60.74 57.81
Support Level $21.64 $22.57
Resistance Level $23.70 $23.94
Average True Range (ATR) 0.45 0.75
MACD 0.18 0.07
Stochastic Oscillator 89.55 73.42

Price Performance

Historical Comparison
DEA
PCRX

About DEA Easterly Government Properties Inc.

Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: